Caenorhabditis elegans susceptibility to gut Enterococcus faecalis infection is associated with fat metabolism and epithelial junction integrity. by Sim, Shuzhen & Hibberd, Martin L
Sim, S; Hibberd, ML (2016) Caenorhabditis elegans susceptibility to
gut Enterococcus faecalis infection is associated with fat metabolism
and epithelial junction integrity. BMC Microbiol, 16 (1). p. 6. ISSN
1471-2180 DOI: 10.1186/s12866-016-0624-8
Downloaded from: http://researchonline.lshtm.ac.uk/2532142/
DOI: 10.1186/s12866-016-0624-8
Usage Guidelines
Please refer to usage guidelines at http://researchonline.lshtm.ac.uk/policies.html or alterna-
tively contact researchonline@lshtm.ac.uk.
Available under license: http://creativecommons.org/licenses/by/2.5/
RESEARCH ARTICLE Open Access
Caenorhabditis elegans susceptibility to gut
Enterococcus faecalis infection is associated
with fat metabolism and epithelial junction
integrity
Shuzhen Sim1* and Martin L. Hibberd1,2
Abstract
Background: Gut bacteria-host interactions have been implicated in the pathogenesis of numerous human diseases,
but few mechanisms have been described. The genetically tractable nematode worm Caenorhabditis elegans can be
infected with pathogenic bacteria, such as the human gut commensal Enterococcus faecalis, via feeding, making it a
good model for studying these interactions.
Results: An RNAi screen of 17 worm candidate genes revealed that knockdown of the transcription factor nhr-49,
a master regulator of fat metabolism, shortens worm lifespan upon infection with E. faecalis (and other potentially
pathogenic bacteria) compared to Escherichia coli. The functional similarity of nhr-49 to the mammalian peroxisome
proliferator-activated receptors (PPARs) suggests that this is mediated through a link between fatty acid metabolism
and innate immunity. In addition, knockdown of either dlg-1 or ajm-1, which encode physically interacting proteins in
the C. elegans epithelial junction, also reduces worm lifespan upon E. faecalis challenge, demonstrating the importance
of the intestinal epithelium as an immune barrier.
Conclusions: The protective roles identified for nhr-49, dlg-1, and ajm-1 suggest mechanistic interactions between
the gut microbiota, host fatty acid metabolism, innate immunity, and epithelial junction integrity that are remarkably
similar to those implicated in human metabolic and inflammatory diseases.
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Background
The human gastrointestinal tract harbors an enormous
number and variety of microbes, with a collective gen-
ome size estimated at ~150 times the complement of
human genes [1]. These organisms, collectively termed
the gut microbiome, carry out crucial metabolic and bio-
logical functions. They aid in food digestion and nutrient
uptake, play important roles in the development of the
immune system and intestinal epithelial barrier, and
compete with potentially pathogenic microorganisms,
thus curbing their growth (reviewed in [2, 3]). Studies of
germ-free or gnotobiotic mice have shown that these
microbes also have local and systemic effects outside of
the gut [4–8], highlighting the complex nature of their
interactions with the host, although the mechanisms of
these interactions require further research.
Disturbances of the gut microbiome through factors
such as diet, antibiotic treatment, or pathogen invasion
can lead to dysbiosis, in which there is an outgrowth of
potentially pathogenic bacteria and a decrease in beneficial
bacteria. The consequent alteration in host interactions is
thought to result in a perturbed immune balance, which
has been linked to the pathogenesis of diverse intestinal
and systemic human diseases (reviewed in [9–11]). These
include inflammatory bowel diseases (IBD) such as ulcera-
tive colitis and Crohn’s disease [12–15], and metabolic
disorders or conditions such as metabolic syndrome, obes-
ity, and type 2 diabetes (T2D) [16–19].
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Further evidence comes from the perspective of human
genetics (reviewed in [20]). Genome-wide association
studies (GWAS) have identified loci associated with sus-
ceptibility to IBD [21–23] and T2D [24, 25] that are also
associated with microbial defense, thus supporting a role
for host-microbiome interactions in disease pathogenesis.
For example, NOD2, the first gene to be associated with
IBD, encodes an intracellular pattern recognition receptor
that mediates the host immune response to the bacterial
peptidoglycan product muramyl dipeptide (MDP) [26];
other IBD-associated genes with roles in anti-bacterial im-
munity include CARD9, IL23R, and LRRK2 [21–23]. Inter-
estingly, there is considerable overlap between risk loci for
Crohn’s disease and leprosy [27–29], suggesting a poten-
tial mycobacterial component to the pathogenesis of IBD.
However, studies that have reported links between micro-
bial dysbiosis, host genetics, and disease often lack direct
causal or functional evidence.
To address this lack of functional evidence, we have uti-
lized the genetically tractable nematode worm Caenorhab-
ditis elegans, a commonly used model for understanding
microbial host-pathogen interactions [30–33]. Since C. ele-
gans is a bacterivore, intestinal infection can be achieved
through feeding, making it especially ideal for investigating
interactions with gut bacteria. In this study, to identify po-
tentially pathogenic host-microbiome interactions, we
selected nematode candidate genes whose orthologs or
functionally related genes in the human have previously
been implicated in metabolic or inflammatory diseases. An
RNAi screen of these genes identified two aspects of
nematode biology—fatty acid metabolism and epithelial
junction integrity—that are involved in C. elegans defense
against the human gut commensal Enterococcus faecalis,
an opportunistic pathogen commonly associated with
hospital-acquired, multidrug-resistant infections [34].
Results
Knockdown of nhr-49 or dlg-1 reduces nematode lifespan
upon OG1RF challenge
OG1RF, an E. faecalis strain of human origin, kills C. ele-
gans by establishing a persistent infection in the nema-
tode intestine, where it proliferates extensively from a
small initial inoculum and causes gross distention [31].
The thick cell wall of E. faecalis is thought to protect it
against the C. elegans grinder organ, which normally dis-
rupts ingested bacteria [31].
To identify host-bacteria interactions during E. faecalis
infection of C. elegans, we performed RNAi knockdowns of
17 candidate C. elegans genes (Additional file 1: Table S1),
screening for impact on nematode survival upon OG1RF
challenge. These candidates have functional domains that
suggest potential interactions with bacteria, but had not
previously been characterized in the context of microbial
infection in the nematode. In addition, their human
orthologs or functionally related genes have been impli-
cated in metabolic and inflammatory diseases.
Knockdown of two candidate genes—nhr-49 and dlg-
1—resulted in a significant decrease in nematode life-
span upon exposure to OG1RF, compared to the RNAi
vector control (Fig. 1a). As has been previously reported
[35], knockdown of nhr-49 on OP50 also resulted in a
significant decrease in lifespan (Fig. 1b). However, this re-
duction (from a median of 10 days to 7 days) was not as
severe as compared to knockdown on OG1RF (from un-
defined, i.e. end-point survival exceeded 50 %, to 6 days)
(p < 0.0001) (Fig. 1b). Knockdown of dlg-1 on OP50 had
no effect on lifespan (Fig. 1c).
nhr-49 and dlg-1 impact C. elegans interactions with other
bacteria
We also examined the effect of nhr-49 and dlg-1 knock-
down on nematode lifespan upon challenge with other
potentially pathogenic bacteria species. Streptococcus gallo-
lyticus gallolyticus (previously classified as S. bovis) is a
Gram-positive opportunistic human pathogen that has con-
sistently been associated with colorectal cancer, although a
direct causal link has yet to be established [36, 37]. Knock-
down of nhr-49 or dlg-1 on SGG53, a clinical S. gallolyticus
gallolyticus isolate, also resulted in a significant reduction
in nematode lifespan (Fig. 2a and b).
The non-pathogenic, fast-growing Mycobacterium smeg-
matis strain mc(2)155 is often used as a laboratory model
of mycobacterial disease. GWAS have reported an overlap
between susceptibility genes for leprosy (caused by Myco-
bacterium leprae) and Crohn’s disease [27–29]; Mycobac-
terium avium paratuberculosis has also been linked to
Crohn’s (reviewed in [38]). While these studies hint at a
potential mycobacterial component to the pathogenesis of
IBD, this has not been substantiated with direct evidence.
Here, knockdown of nhr-49 on mc(2)155 also significantly
reduced nematode lifespan (Fig. 2c), whereas dlg-1 knock-
down on mc(2)155 showed no effect (Fig. 2d).
Because median lifespans for nematodes maintained
on SGG53 and mc(2)155 were undefined, we could not
tell if the lifespan reduction seen upon nhr-49 knock-
down on these bacteria was more or less severe than for
knockdown on OP50 (Fig. 2a and c).
Taken together, the data suggest that nhr-49 affects in-
teractions with OG1RF, SGG53, and mc(2)155, with the
greatest impact on OG1RF, while dlg-1 affects interac-
tions with OG1RF and SGG53.
Knockdown of nhr-49 transcriptional targets does not
impact survival on OG1RF
nhr-49 encodes a nuclear hormone receptor master
regulator of fat metabolism. Loss of nhr-49 increases fat
content and reduces lifespan in nematodes maintained
on OP50 [35]. nhr-49 enhances expression of acs-2, a
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mitochondrial acyl-CoA synthetase, and ech-1, a mito-
chondrial β-oxidation trifunctional enzyme, thus pro-
moting the flow of fatty acids into the mitochondria for
use in energy production. nhr-49 also enhances expres-
sion of fat-7, a stearoyl-CoA desaturase, thus maintain-
ing proper balance of saturated to unsaturated fatty
acids. fat-7 is involved in a negative feedback mechanism
that inhibits acs-2 and ech-1 expression, possibly by sig-
naling through an as-yet-unidentified fatty acid species
[35] (Fig. 3a).
We examined the effect of OG1RF challenge on nhr-
49, acs-2, ech-1, and fat-7 expression by quantitative RT-
PCR. By 7 days post-OG1RF challenge, the transcript
abundance of acs-2 was induced ~200-fold (p = 0.0004)
relative to nematodes maintained on OP50 (Fig. 4a).
We next determined if OG1RF induction of acs-2
was dependent on nhr-49 or fat-7. Knockdown of nhr-
49 resulted in a moderately stronger induction of acs-2
upon OG1RF challenge (222-, 163-, and 56-fold versus
54-, 8, and 33-fold relative to worms on OP50) (Fig. 4b).
Knockdown of fat-7 resulted in a much more appre-
ciable and consistent induction of acs-2 (178-, 368-,
and 916-fold versus 54-, 8-, and 33-fold relative to
worms on OP50) (Fig. 4b). However, due to the large
range of the data, a student’s t-test did not find these
changes statistically significant. These data underscore
Fig. 1 Effect of gene knockdown on C. elegans lifespan upon challenge with OG1RF. a Kaplan-Meier survival curves showing the effect of nhr-49
and dlg-1 knockdown upon challenge with OG1RF. b-c Data from (a) shown alongside survival curves for nhr-49 and dlg-1 knockdown upon
challenge with OP50; OG1RF and OP50 survival assays were performed on separate occasions. Data represent three biological replicates with 20–30
nematodes each; p-values indicate comparisons between gene knockdown and empty vector for the same bacteria
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the role of fat-7 as a negative regulator of acs-2, and
suggest that nhr-49 depletion and subsequent reduced
fat-7 transcription may result in moderate loss of this
regulation. The relative balance between nhr-49 and
fat-7 levels are likely to contribute to the variability in
the data.
Despite its strong induction by OG1RF, knockdown
of acs-2 had no effect on nematode lifespan after bac-
terial challenge. Similarly, knockdown of either fat-7
or ech-1 separately did not impact lifespan after bac-
terial challenge (Fig. 5a).
Knockdown of the dlg-1-interacting gene ajm-1 shortens
lifespan on OG1RF
dlg-1 encodes a protein that physically interacts with AJM-
1 in the C. elegans epithelial junction. The DLG-1 / AJM-1
complex is targeted to apical junctions by LET-413 (Fig. 3b)
(reviewed in [39]).
Fig. 2 Effect of gene knockdown on C. elegans lifespan upon challenge with other bacteria. Kaplan-Meier survival curves showing effect of nhr-49
and dlg-1 knockdown upon challenge with (a-b) SGG53 and (c-d) mc(2)155. Survival curves for gene knockdowns on OP50, performed on a separate
occasion, are also shown. Data represent three biological replicates with 20–30 nematodes each; p-values indicate comparisons between gene
knockdown and empty vector for the same bacteria
Fig. 3 Modes of action of nhr-49 and dlg-1. a nhr-49 encodes a nuclear hormone receptor that enhances the expression of acs-2 and ech-1, facilitating
the flow of fatty acids into the mitochondrial matrix. nhr-49 also maintains a normal balance of saturated and unsaturated fatty acids by enhancing
expression of fat-7. Deletion or depletion of nhr-49 increases fat content and reduces lifespan in C. elegans maintained on OP50. fat-7 is involved in a
negative feedback mechanism that inhibits acs-2 and ech-1 expression, possibly by signaling through an as-yet unidentified fatty acid species. b dlg-1
encodes a protein that physically interacts with ajm-1 in the C. elegans epithelial junction. The DLG-1 / AJM-1 complex is targeted to apical junctions
by LET-413, and may be linked to the cell membrane by claudin-like transmembrane proteins such as VAB-9 or CLC-1. See text for more details; figures
have been adapted from [35, 39]
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OG1RF infection did not modulate dlg-1, ajm-1, or let-
413 expression (Fig. 4a). Knockdown of ajm-1 resulted in
a significant decrease in lifespan for nematodes main-
tained on OG1RF (Fig. 5a) but not on OP50 (Fig. 5b);
knockdown of let-413 did not impact lifespan on OG1RF
(Fig. 5a).
Discussion
Insights from human GWAS and studies of germ-free ani-
mals suggest that host-microbiome interactions may play
roles in triggering inflammatory and metabolic diseases
(reviewed in [11, 20]). However, as causative organisms
and disease mechanisms have yet to be definitively identi-
fied, this concept remains largely speculative. To ad-
dress this lack of functional evidence, we used the C.
elegans model system to identify potentially pathogenic
host-microbe interactions. We identified two aspects of
host physiology—fat metabolism and epithelial junction
integrity—that E. faecalis interacts with during the kill-
ing of C. elegans.
Depletion of nhr-49, which encodes a nuclear hormone
receptor and master regulator of fat metabolism, shortens
worm lifespan upon E. faecalis infection. nhr-49 shares
strong sequence similarity with the mammalian hepato-
cyte nuclear factor 4 (HNF4) receptors; mutations in
HNF-4A are associated with maturity onset diabetes of
the young 1 (MODY1) and T2D (reviewed in [40]). How-
ever, nhr-49′s effects on fat metabolism and lifespan are
more closely analogous to those of the mammalian per-
oxisome proliferator-activated receptors (PPARs) [35].
PPARs—nuclear hormone receptor transcription factors
activated by fatty acids and their derivatives—are key reg-
ulators of metabolism and controllers of inflammation
(reviewed in [41]), and are promising targets for the treat-
ment of metabolic syndrome and IBD [42–44].
Obesity, insulin resistance, and other metabolic
syndrome-related conditions are characterized by chronic,
low-grade inflammation in metabolic tissues such as adi-
pose tissue, liver, skeletal muscle, and blood vessel walls
[11, 41]. Studies in mice have found that gut bacteria-
Fig. 4 Effect of OG1RF challenge on C. elegans gene expression. a Fold change in gene expression at 3 and 7 days post-OG1RF challenge, relative
to nematodes grown on OP50. b Fold change in acs-2 expression upon gene knockdown, at 3 and 7 days post-OG1RF challenge, relative to gene
knockdown on OP50
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derived lipopolysaccharide (LPS) can initiate this inflam-
matory state, and consequently obesity and insulin resist-
ance, by binding to CD14-TLR4 complexes on immune
cells [45, 46]. High fat diets can cause changes in the gut
microbiota composition that result in increased circulating
LPS levels [45].
PPARs control inflammation through multiple mecha-
nisms (reviewed in [41]). In adipose tissue and the liver, the
presence of alternatively activated macrophages (AAMs),
which dampen inflammation and improve insulin sensi-
tivity, is maintained by PPAR-dependent mechanisms
[47, 48]. PPARs also reduce inflammation in muscle
cells by regulating saturated fatty acid metabolism away
from diacylglycerol accumulation, thus avoiding NF-ĸB
activation [49].
PPARs also regulate inflammation in the intestinal epi-
thelium, and there is ample evidence for more direct,
local interactions between these molecules and gut bac-
teria. For example, the human gut commensal Bacter-
oides thetaiotaomicron enhances complex formation
between PPARγ and the NF-ĸB subunit RelA in human
intestinal cell lines, resulting in PPARγ-dependent nu-
clear export of RelA and subsequent suppression of pro-
inflammatory cytokine production [50]. In addition, E.
faecalis isolated from newborn babies induces phosphor-
ylation and activation of PPARγ in colonic epithelial cell
lines and primary colonic cells, resulting in transcrip-
tional activation of target genes, including the immune-
modulatory cytokine IL-10 [51]. These studies suggest
potential links between fatty acid signaling / metabolism
and innate immunity [41], and, similar to what we ob-
serve here for nhr-49, a protective role for PPARγ in gut
homeostasis.
In our study, E. faecalis infection strongly induced ex-
pression of the nhr-49 transcriptional target acs-2, an
acyl-CoA synthetase that activates fatty acids for β-
oxidation and energy production in the mitochondria.
Both pathogenic and commensal bacteria, including E.
faecalis, have been reported to regulate host energy pro-
duction pathways, presumably to increase levels of
Fig. 5 Effect of knockdown of nhr-49- and dlg-1-interacting genes on C. elegans lifespan upon challenge with OG1RF. a Kaplan-Meier survival curves
showing effect of gene knockdown upon challenge with OG1RF. b Kaplan-Meier survival curves showing effect of ajm-1 knockdown on OP50
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metabolites required for their own growth [52–54]. How-
ever, acs-2 depletion had no effect on nematode lifespan
upon bacterial challenge, suggesting that acs-2-dependent
metabolites may not be limiting to E. faecalis growth.
Consistent with this, depletion of the acs-2 negative regu-
lator fat-7 also did not impact lifespan upon E. faecalis
challenge, despite a marked increase in acs-2 induction.
These data suggest that the protective effect of nhr-49
may be mediated through one or more of its other tran-
scriptional targets [35], which may have as-yet uncharac-
terized roles in innate immunity. Alternatively, analogous
to what has been reported for PPARγ and RelA [50], this
effect could also be mediated through a physical inter-
action between NHR-49 and other nuclear hormone
receptor family members [55]. Finally, although the vast
majority of nhr-49 transcriptional targets play roles in fat
metabolism [35, 56, 57], the possibility of OG1RF sensitiv-
ity being mediated by targets that affect other biological
processes remains open.
Depletion of dlg-1 or ajm-1 also resulted in reduced
worm lifespan upon E. faecalis challenge. The DLG-1 /
AJM-1 complex is a critical component of the C. elegans
apical epithelial junction, which, as in other organisms, me-
diates cellular permeability, adhesion between neighboring
cells, and cell polarity (reviewed in [39]). Loss of either pro-
tein results in developmental arrest at the embryonic
elongation stage [58, 59]: Loss of dlg-1, which encodes a
Membrane Associated GUanylate Kinase (MAGUK) pro-
tein family member, results in disappearance of the
electron-dense apical junction structure in epidermal and
intestinal epithelia, as well as mislocalization of AJM-1
[58]. Loss of ajm-1, encoding a novel protein with a large
coiled-coil domain, produces bubble-like separations at
cell-cell junctions that are normally in close apposition
[59]. Here, we show that depletion of dlg-1 or ajm-1 from
the L1 stage onwards affects the susceptibility of adult
worms to bacteria, suggesting that epithelial junction integ-
rity constitutes an important gut defense mechanism.
Although the role of DLG-1 / AJM-1 in apical junction
integrity is well-characterized, a link between this and intes-
tinal permeability remains to be demonstrated. This may be
mediated through the claudin CLC-1, which is thought to
interact with DLG-1 / AJM-1 at the cell surface—CLC-1-
deficient nematodes show compromised barrier function in
the pharyngeal portion of the intestine, and leak ingested
dye into the body cavity [60]. We hypothesize, however,
that increased sensitivity to bacteria-derived toxins or small
molecules (rather than dissemination of entire bacterial
cells beyond the intestine) may be sufficient to bring about
increased pathogen susceptibility.
The role of dlg-1 in the maintenance of the intestinal
epithelial immune barrier appears to be conserved in
Drosophila, where depletion of its fly homolog discs large
(dlg), a key component of the fly epithelial junction, results
in over-proliferation of intestinal cells upon Pseudomonas
aeruginosa infection [61]. Loss of other Drosophila epithe-
lial junction components has also been reported to com-
promise gut defenses; notably, loss of the big bang (bbg)
gene, which encodes a membrane-associated PDZ (PSD-
95, Discs-large, ZO-1) domain-containing protein, loosens
epithelial junctions, allowing intestinal bacteria to consti-
tutively activate fly midgut immune responses. The result-
ing chronic epithelial inflammation reduces lifespan [62].
While not fully understood, human IBD is also thought
to stem from a breach in the intestinal epithelium, which
exposes immune cells in the underlying lamina propria to
bacteria or bacterial products from the gut (reviewed in
[63]). Genetic variants in DLG5 (a human homolog of C.
elegans dlg-1 and Drosophila dlg) are associated with IBD
[64, 65], and intestinal permeability has been correlated
with peripheral immune activation and clinical relapse in
patients with Crohn’s disease [66, 67]. In IL-10 knockout
mouse models of IBD, an unchecked TH1 inflammatory
response is associated with increased intestinal permeabil-
ity [68]; other mouse models indicate that disruption of
intestinal epithelial junction integrity alone, through ex-
pression of dominant negative E-cadherin, is sufficient to
initiate the disease [69]. In addition, consistent with the
concept of gut bacteria-initiated systemic inflammation,
increased intestinal permeability has been associated with
metabolic conditions such as obesity, increased visceral
adiposity, and fatty liver, both in patients and in animal
models [70, 71].
Conclusions
We identified protective roles for nhr-49, dlg-1, and ajm-1
in C. elegans defense against the human gut commensal E.
faecalis. The involvement of these genes suggests intri-
guing interactions between gut bacteria and the host pro-
cesses of fatty acid metabolism, innate immunity, and
epithelial junction integrity that consequently impact
nematode survival. These data lend mechanistic support
to the concept of gut microbiota dysbiosis in humans,
where remarkably similar interactions have been proposed
as a basis for the pathogenesis of inflammatory and meta-
bolic diseases.
Methods
Nematode and bacteria strains
The C. elegans strain SS104 glp-4(bn2)I, a temperature-
sensitive mutant that grows permissively at 15 °C but
produces no progeny at 25 °C [72], was used in survival
assays. This was maintained at 15 °C on nematode
growth media (NGM) agar and fed on the OP50 Escheri-
chia coli strain, as described previously [73].
E. coli OP50 was grown at 37 °C in Luria-Bertani (LB)
broth. OG1RF (ATCC accession number 47077), an En-
terococcus faecalis strain of human origin, was grown in
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brain-heart infusion (BHI) broth (BD) at 37 °C. SGG53, a
Streptococcus gallolyticus gallolyticus clinical isolate, was
grown at 37 °C in tryptic soy (TS) broth (BD). mc(2)155
(ATCC accession number 700084), a Mycobacterium smeg-
matis strain, was grown at 37 °C in Middlebrook 7H9 broth
supplemented with ADC enrichment (BD).
RNAi knockdown of candidate genes
Nematodes were fed on HT115 (DE3) E. coli clones trans-
formed with either the empty L4440 vector (control), or the
L4440 vector containing a gene-specific amplicon. RNAi
constructs were either obtained from the Ahringer RNAi
library [74] or created by cloning gene-specific amplicons
into L4440 vector. Sequences of primers used for PCR
amplification are listed in Additional file 2: Table S2.
Each clone was grown for 8 h in LB broth supplemented
with 50 μg/ml ampicillin, seeded on NGM agar plates sup-
plemented with 25 μg/ml carbenicillin and 1 mM β-D-1-
thiogalactopyranoside (IPTG), and left to induce overnight
at room temperature. Nematode embryos, generated by
hypochlorite treatment, were grown on these plates
until the L4 stage, and subsequently transferred to
pathogen lawns.
Survival assays
Pathogens were grown overnight in their respective li-
quid media at 37 °C, seeded onto their respective agar
plates, and left to form lawns overnight at 37 °C. To
minimize transfer of HT115 E. coli, L4-stage nematodes
were allowed to crawl on bare agar before they were
transferred to pathogen lawns. Subsequently, nematodes
were transferred to fresh pathogen lawns every other day
to further prevent growth of residual HT115 E. coli; none
was visually observed. Nematode survival was monitored
daily; nematodes were considered dead if they failed to re-
spond to gentle touch with a platinum wire. The data pre-
sented are a pool of three independent experiments, with
20–30 nematodes each. Survival assays for OP50 and for
each bacterial pathogen were performed on separate occa-
sions; however, statistical comparisons presented in the
Figures were made only within the same assay.
Quantitative real-time PCR analysis
Nematodes were collected in 1 ml Trizol, and lysed by
freeze-thawing. RNA was extracted from lysates with
the Qiagen RNeasy Mini Kit (Qiagen), DNAse-treated
(ThermoScientific), and used for cDNA synthesis with
the Maxima H Minus First Strand cDNA Synthesis Kit
(ThermoScientific). qRT-PCR was performed with the
KAPA SYBR FAST qPCR Master Mix (KAPA Biosci-
ences) on the LightCycler 480 II real-time thermocycler
(Roche Applied Science). Raw values were normalized
to each of three control genes (act-1, nhr-23, and ama-
1); the average of the normalized values was then used
for analysis [75]. Primer sequences used in qRT-PCR
are presented in Additional file 3: Table S3.
Statistical analysis
Kaplan-Meier survival curve analysis and student t-tests
were carried out with GraphPad Prism 3.
Additional files
Additional file 1: Table S1. C. elegans candidate genes screened via
RNAi knockdown. IBD, inflammatory bowel disease; T2D, type 2 diabetes;
KD, Kawasaki Disease. (DOCX 15 kb)
Additional file 2: Table S2. Sequences of primers used for PCR
amplification of gene-specific amplicons for cloning into the L4440
RNAi vector. RNAi constructs for candidate genes not listed here were
obtained from the Ahringer RNAi library [74]. (DOCX 12 kb)
Additional file 3: Table S3. Sequences of primers used for quantitative
RT-PCR. (DOCX 12 kb)
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SS designed and performed the experiments, analyzed the data, and wrote
the manuscript. MLH conceived of the study and helped with experimental
design, data analysis, and manuscript writing. Both authors read and
approved the final manuscript.
Acknowledgments
This study was supported by the Agency for Science, Technology, and Research
(A*STAR), Singapore. We thank Xiaohui Sem (Singapore Immunology Network)
and Patrick Tan (Genome Institute of Singapore) for C. elegans strains and
materials, and help with experimental techniques. We are grateful to Jan Gruber
and Lifang Ng (Yale-National University of Singapore) for help with experimental
techniques. We also thank Shugui Wang and Sven Pettersson (National Cancer
Center) for providing the SGG53 S. gallolyticus gallolyticus strain.
Author details
1Infectious Diseases, Genome Institute of Singapore, 60 Biopolis Street,
#02-01 Genome, Singapore 138672, Singapore. 2Faculty of Infectious and
Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel
Street, London WC1E 7HT, United Kingdom.
Received: 2 September 2015 Accepted: 8 January 2016
References
1. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al. A human
gut microbial gene catalogue established by metagenomic sequencing.
Nature. 2010;464:59–65.
2. Zhang Y-J, Li S, Gan R-Y, Zhou T, Xu D-P, Li H-B. Impacts of gut bacteria on
human health and diseases. Int J Mol Sci. 2015;16:7493–519.
3. Ivanov II, Honda K. Intestinal commensal microbes as immune modulators.
Cell Host Microbe. 2012;12:496–508.
4. Cadwell K, Patel KK, Maloney NS, Liu T-C, Ng ACY, Storer CE, et al. Virus-plus-
susceptibility gene interaction determines Crohn’s disease gene Atg16L1
phenotypes in intestine. Cell. 2010;141:1135–45.
5. Björkholm B, Bok CM, Lundin A, Rafter J, Hibberd ML, Pettersson S.
Intestinal microbiota regulate xenobiotic metabolism in the liver. PLoS
One. 2009;4, e6958.
6. Heijtz RD, Wang S, Anuar F, Qian Y, Björkholm B, Samuelsson A, et al.
Normal gut microbiota modulates brain development and behavior.
Proc Natl Acad Sci. 2011;108:3047–52.
7. Lundin A, Bok CM, Aronsson L, Björkholm B, Gustafsson J-Å, Pott S, et al.
Gut flora, Toll-like receptors and nuclear receptors: a tripartite communication
that tunes innate immunity in large intestine. Cell Microbiol. 2008;10:1093–103.
Sim and Hibberd BMC Microbiology  (2016) 16:6 Page 8 of 10
8. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut
microbiota as an environmental factor that regulates fat storage. Proc Natl
Acad Sci U S A. 2004;101:15718–23.
9. Bäckhed F, Fraser CM, Ringel Y, Sanders ME, Sartor RB, Sherman PM, et al.
Defining a healthy human gut microbiome: current concepts, future
directions, and clinical applications. Cell Host Microbe. 2012;12:611–22.
10. Dalal SR, Chang EB. The microbial basis of inflammatory bowel diseases.
J Clin Invest. 2014;124:4190–6.
11. Musso G, Gambino R, Cassader M. Obesity, diabetes, and gut microbiota the
hygiene hypothesis expanded? Diabetes Care. 2010;33:2277–84.
12. Willing BP, Dicksved J, Halfvarson J, Andersson AF, Lucio M, Zheng Z, et al.
A pyrosequencing study in twins shows that gastrointestinal microbial
profiles vary with inflammatory bowel disease phenotypes.
Gastroenterology. 2010;139:1844–54. e1.
13. Lupp C, Robertson ML, Wickham ME, Sekirov I, Champion OL, Gaynor EC,
et al. Host-mediated inflammation disrupts the intestinal microbiota and
promotes the overgrowth of enterobacteriaceae. Cell Host Microbe.
2007;2:119–29.
14. Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al.
Dysfunction of the intestinal microbiome in inflammatory bowel disease
and treatment. Genome Biol. 2012;13:R79.
15. Sokol H, Pigneur B, Watterlot L, Lakhdari O, Bermúdez-Humarán LG,
Gratadoux J-J, et al. Faecalibacterium prausnitzii is an anti-inflammatory
commensal bacterium identified by gut microbiota analysis of Crohn
disease patients. Proc Natl Acad Sci. 2008;105:16731–6.
16. Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association
study of gut microbiota in type 2 diabetes. Nature. 2012;490:55–60.
17. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI.
An obesity-associated gut microbiome with increased capacity for energy
harvest. Nature. 2006;444:1027–131.
18. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut
microbes associated with obesity. Nature. 2006;444:1022–3.
19. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE, et al.
A core gut microbiome in obese and lean twins. Nature. 2009;457:480–4.
20. Khor CC, Hibberd ML. Host–pathogen interactions revealed by human
genome-wide surveys. Trends Genet. 2012;28:233–43.
21. Anderson CA, Boucher G, Lees CW, Franke A, D’Amato M, Taylor KD, et al.
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing
the number of confirmed associations to 47. Nat Genet. 2011;43:246–52.
22. Franke A, McGovern DPB, Barrett JC, Wang K, Radford-Smith GL, Ahmad T,
et al. Genome-wide meta-analysis increases to 71 the number of confirmed
Crohn’s disease susceptibility loci. Nat Genet. 2010;42:1118–25.
23. McGovern DPB, Gardet A, Törkvist L, Goyette P, Essers J, Taylor KD, et al.
Genome-wide association identifies multiple ulcerative colitis susceptibility
loci. Nat Genet. 2010;42:332–7.
24. Scott LJ, Mohlke KL, Bonnycastle LL, Willer CJ, Li Y, Duren WL, et al.
A genome-wide association study of type 2 diabetes in Finns detects
multiple susceptibility variants. Science. 2007;316:1341–5.
25. Burton PR, Clayton DG, Cardon LR, Craddock N, Deloukas P, Duncanson A,
et al. Genome-wide association study of 14,000 cases of seven common
diseases and 3,000 shared controls. Nature. 2007;447:661–78.
26. Inohara N, Ogura Y, Fontalba A, Gutierrez O, Pons F, Crespo J, et al. Host
recognition of bacterial Muramyl Dipeptide Mediated through NOD2
IMPLICATIONS FOR CROHN’S DISEASE. J Biol Chem. 2003;278:5509–12.
27. Wong SH, Gochhait S, Malhotra D, Pettersson FH, Teo YY, Khor CC, et al.
Leprosy and the adaptation of human toll-like receptor 1. PLoS Pathog.
2010;6, e1000979.
28. Zhang F, Liu H, Chen S, Low H, Sun L, Cui Y. Identification of two new loci
at IL23R and RAB32 that influence susceptibility to leprosy. Nat Genet.
2011;43:1247–51.
29. Zhang F-R, Huang W, Chen S-M, Sun L-D, Liu H, Li Y, et al. Genomewide
association study of leprosy. N Engl J Med. 2009;361:2609–18.
30. Sem X, Rhen M. Pathogenicity of salmonella enterica in Caenorhabditis
elegans Relies on disseminated oxidative stress in the infected host. PLoS
One. 2012;7, e45417.
31. Garsin DA, Sifri CD, Mylonakis E, Qin X, Singh KV, Murray BE, et al. A simple
model host for identifying Gram-positive virulence factors. Proc Natl Acad
Sci. 2001;98:10892–7.
32. Bolm M, Jansen WTM, Schnabel R, Chhatwal GS. Hydrogen peroxide-
mediated killing of Caenorhabditis elegans: a common feature of different
streptococcal species. Infect Immun. 2004;72:1192–4.
33. Kirienko NV, Kirienko DR, Larkins-Ford J, Wählby C, Ruvkun G, Ausubel FM.
Pseudomonas aeruginosa disrupts caenorhabditis elegans iron homeostasis,
causing a hypoxic response and death. Cell Host Microbe. 2013;13:406–16.
34. Palmer KL, Kos VN, Gilmore MS. Horizontal gene transfer and the genomics
of enterococcal antibiotic resistance. Curr Opin Microbiol. 2010;13:632–9.
Antimicrobials/Genomics.
35. Gilst MRV, Hadjivassiliou H, Jolly A, Yamamoto KR. Nuclear hormone
receptor nhr-49 controls fat consumption and fatty acid composition in C.
elegans. PLoS Biol. 2005;3:e53.
36. Collins D, Hogan AM, Winter DC. Microbial and viral pathogens in colorectal
cancer. Lancet Oncol. 2011;12:504–12.
37. Boleij A, Muytjens CMJ, Bukhari SI, Cayet N, Glaser P, Hermans PWM, et al.
Novel clues on the specific association of streptococcus gallolyticus subsp
gallolyticus with colorectal cancer. J Infect Dis. 2011;203:1101–9.
38. Packey CD, Sartor RB. Commensal bacteria, traditional and opportunistic
pathogens, dysbiosis and bacterial killing in inflammatory bowel diseases.
Curr Opin Infect Dis. 2009;22:292–301.
39. Lynch AM, Hardin J. The assembly and maintenance of epithelial junctions
in C. elegans. Front Biosci J Virtual Libr. 2009;14:1414–32.
40. Gupta RK, Kaestner KH. HNF-4α: from MODY to late-onset type 2 diabetes.
Trends Mol Med. 2004;10:521–4.
41. Wahli W, Michalik L. PPARs at the crossroads of lipid signaling and
inflammation. Trends Endocrinol Metab. 2012;23:351–63. Special Focus:
Mammalian Circadian Rhythms and Metabolism.
42. Larsen TM, Toubro S, Astrup A. PPARgamma agonists in the treatment of
type II diabetes: is increased fatness commensurate with long-term efficacy?
Int J Obes. 2003;27:147–61.
43. Annese V, Rogai F, Settesoldi A, Bagnoli S. PPARgamma in inflammatory
bowel disease. PPAR Res. 2012;2012, e620839.
44. Wilding JPH. PPAR agonists for the treatment of cardiovascular disease in
patients with diabetes. Diabetes Obes Metab. 2012;14:973–82.
45. Cani PD, Amar J, Iglesias MA, Poggi M, Knauf C, Bastelica D, et al.
Metabolic endotoxemia initiates obesity and insulin resistance.
Diabetes. 2007;56:1761–72.
46. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM, et al.
Changes in gut microbiota control metabolic endotoxemia-induced
inflammation in high-fat diet–induced obesity and diabetes in mice.
Diabetes. 2008;57:1470–81.
47. Odegaard JI, Ricardo-Gonzalez RR, Goforth MH, Morel CR, Subramanian V,
Mukundan L, et al. Macrophage-specific PPARγ controls alternative
activation and improves insulin resistance. Nature. 2007;447:1116–20.
48. Odegaard JI, Ricardo-Gonzalez RR, Eagle AR, Vats D, Morel CR, Goforth MH,
et al. Alternative (M2) activation of Kupffer cells by PPARδ ameliorates
obesity-induced insulin resistance. Cell Metab. 2008;7:496–507.
49. Coll T, Álvarez-Guardia D, Barroso E, Gómez-Foix AM, Palomer X, Laguna JC,
et al. Activation of peroxisome proliferator-activated receptor-δ by
GW501516 prevents fatty acid-induced nuclear factor-κB activation and
insulin resistance in skeletal muscle cells. Endocrinology. 2010;151:1560–9.
50. Kelly D, Campbell JI, King TP, Grant G, Jansson EA, Coutts AGP, et al.
Commensal anaerobic gut bacteria attenuate inflammation by regulating
nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat Immunol.
2004;5:104–12.
51. Are A, Aronsson L, Wang S, Greicius G, Lee YK, Gustafsson J-Å, et al.
Enterococcus faecalis from newborn babies regulate endogenous PPARγ
activity and IL-10 levels in colonic epithelial cells. Proc Natl Acad Sci.
2008;105:1943–8.
52. Wong HEE, Li M-S, Kroll JS, Hibberd ML, Langford PR. Genome wide
expression profiling reveals suppression of host defence responses during
Colonisation by Neisseria meningitides but not N. lactamica. PLoS One.
2011;6:e26130.
53. Hooper LV, Xu J, Falk PG, Midtvedt T, Gordon JI. A molecular sensor that
allows a gut commensal to control its nutrient foundation in a competitive
ecosystem. Proc Natl Acad Sci. 1999;96:9833–8.
54. Lindenstrauß AG, Ehrmann MA, Behr J, Landstorfer R, Haller D, Sartor RB, et al.
Transcriptome analysis of enterococcus faecalis toward its adaption to
surviving in the mouse intestinal tract. Arch Microbiol. 2014;196:423–33.
55. Li S, Armstrong CM, Bertin N, Ge H, Milstein S, Boxem M, et al. A map of the
interactome network of the Metazoan C. elegans. Science. 2004;303:540–3.
56. Gilst MRV, Hadjivassiliou H, Yamamoto KR. A Caenorhabditis elegans
nutrient response system partially dependent on nuclear receptor NHR-49.
Proc Natl Acad Sci U S A. 2005;102:13496–501.
Sim and Hibberd BMC Microbiology  (2016) 16:6 Page 9 of 10
57. Fredens J, Færgeman NJ. Quantitative proteomics by amino acid
labeling identifies novel NHR-49 regulated proteins in C. elegans. Worm.
2012;1:66–71.
58. McMahon L, Legouis R, Vonesch J-L, Labouesse M. Assembly of C.
elegans apical junctions involves positioning and compaction by LET-
413 and protein aggregation by the MAGUK protein DLG-1. J Cell Sci.
2001;114:2265–77.
59. Köppen M, Simske JS, Sims PA, Firestein BL, Hall DH, Radice AD, et al.
Cooperative regulation of AJM-1 controls junctional integrity in
Caenorhabditis elegans epithelia. Nat Cell Biol. 2001;3:983–91.
60. Asano A, Asano K, Sasaki H, Furuse M, Tsukita S. Claudins in caenorhabditis
elegans: their distribution and barrier function in the epithelium. Curr Biol.
2003;13:1042–6.
61. Apidianakis Y, Pitsouli C, Perrimon N, Rahme L. Synergy between bacterial
infection and genetic predisposition in intestinal dysplasia. Proc Natl Acad
Sci. 2009;106:20883–8.
62. Bonnay F, Cohen-Berros E, Hoffmann M, Kim SY, Boulianne GL, Hoffmann
JA, et al. big bang gene modulates gut immune tolerance in Drosophila.
Proc Natl Acad Sci U S A. 2013;110:2957–62.
63. Clayburgh DR, Shen L, Turner JR. A porous defense: the leaky epithelial
barrier in intestinal disease. Lab Invest. 2004;84:282–91.
64. Stoll M, Corneliussen B, Costello CM, Waetzig GH, Mellgard B, Koch WA, et
al. Genetic variation in DLG5 is associated with inflammatory bowel disease.
Nat Genet. 2004;36:476–80.
65. Büning C, Geerdts L, Fiedler T, Gentz E, Pitre G, Reuter W, et al. DLG5 variants in
inflammatory bowel disease. Am J Gastroenterol. 2006;101:786–92.
66. Wyatt J, Vogelsang H, Hübl W, Waldhöer T, Lochs H. Intestinal permeability
and the prediction of relapse in Crohn’s disease. Lancet. 1993;341:1437–9.
67. Yacyshyn BR, Meddings JB. CD45RO expression on circulating CD19+ B cells
in Crohn’s disease correlates with intestinal permeability. Gastroenterology.
1995;108:132–7.
68. Davidson NJ, Leach MW, Fort MM, Thompson-Snipes L, Kühn R, Müller W, et
al. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in
interleukin 10-deficient mice. J Exp Med. 1996;184:241–51.
69. Hermiston ML, Gordon JI. Inflammatory bowel disease and adenomas in
mice expressing a dominant negative N-cadherin. Science. 1995;270:1203–7.
70. Gummesson A, Carlsson LMS, Storlien LH, Bäckhed F, Lundin P, Löfgren L, et
al. Intestinal permeability is associated with visceral adiposity in healthy
women. Obesity. 2011;19:2280–2.
71. Brun P, Castagliuolo I, Leo VD, Buda A, Pinzani M, Palù G, et al. Increased
intestinal permeability in obese mice: new evidence in the pathogenesis of
nonalcoholic steatohepatitis. Am J Physiol - Gastrointest Liver Physiol.
2007;292:G518–25.
72. Beanan MJ, Strome S. Characterization of a germ-line proliferation mutation
in C. elegans. Development. 1992;116:755–66.
73. Brenner S. The genetics of Caenorhabditis Elegans. Genetics. 1974;77:71–94.
74. Kamath RS, Fraser AG, Dong Y, Poulin G, Durbin R, Gotta M, et al. Systematic
functional analysis of the Caenorhabditis elegans genome using RNAi.
Nature. 2003;421:231–7.
75. Gaglia MM, Jeong D-E, Ryu E-A, Lee D, Kenyon C, Lee S-J. Genes that act
downstream of sensory neurons to influence Longevity, Dauer formation,
and pathogen responses in Caenorhabditis elegans. PLoS Genet.
2012;8, e1003133.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Sim and Hibberd BMC Microbiology  (2016) 16:6 Page 10 of 10
